ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
2
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,345
similar
All similar
Record
: found
Abstract
: not found
Book Chapter
: not found
Mirati announces clinical collaboration to evaluate MRTX849 in combination with SHP2 inhibitor TNO155
Author(s):
Publication date:
Read this book at
Bookmark
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Clinical Interventions in Aging
Data availability:
Comments
Comment on this book
Sign in to comment
Similar content
3,345
A phase 1 clinical trial evaluating the pharmacokinetics (PK), safety, and clinical activity of MRTX849, a mutant-selective small molecule KRAS G12C inhibitor, in advanced solid tumors
Authors:
P. JANNE
The KRAS(G12C) inhibitor MRTX849 reconditions the tumor immune microenvironment and leads to durable complete responses in combination with anti-PD-1 therapy in a syngeneic mouse model
Authors:
D.M. Briere
,
A. Calinisan
,
R ARANDA
…
Phase 1/2 study of MRTX849 in patients with cancer having a KRAS G12C mutation KRYSTAL-1
Authors:
See all similar
Cited by
1
Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies
Authors:
Zhendong Song
,
Meijing Wang
,
Yang Ge
…
See all cited by